Acadia drug approval could clear way for Axovant dementia therapy

April 28 (Reuters) - An imminent ruling on Acadia

Pharmaceuticals Inc's drug for Parkinson's disease

psychosis is being closely watched by a Bermuda-based company

with a similar treatment for...

Read more